QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vincerx-pharma-q1-eps-058-misses-029-estimate

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0....

 why-vincerx-pharma-vinc-stock-is-falling

Vincerx Pharma shares are trading lower by 9.7% to $0.81 during Friday's session. The company priced an underwritten public...

 vincerx-pharma-sets-pricing-for-new-public-offering-of-shares-and-warrants

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of it...

 vincerx-pharma-announces-proposed-underwritten-public-offering-of-common-stock-and-warrants-no-size-or-amount-disclosed

Vincerx Pharma, Inc. (NASDAQ:VINC) today announced a proposed underwritten public offering of shares of its common stock and ac...

 crude-oil-down-over-1-cognyte-software-shares-plummet

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 dow-dips-150-points-laser-photonics-shares-spike-higher

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded...

 why-is-small-cap-cancer-focused-vincerx-pharma-stock-plummeting-on-tuesday

Preliminary Phase 1 data for VIP236 and updates on pipeline progress presented by Vincerx Pharma at AACR Annual Meeting 2024. R...

 dow-gains-over-50-points-neogen-posts-downbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market openi...

 cantor-fitzgerald-reiterates-overweight-on-vincerx-pharma

Cantor Fitzgerald analyst Li Watsek reiterates Vincerx Pharma (NASDAQ:VINC) with a Overweight.

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 vincerx-pharma-presents-preliminary-phase-1-data-for-vip236-and-updates-on-pipeline-progress-at-aacr-annual-meeting-2024

VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily p...